Publications

  1. Nauman J, Janszky I, Vatten LJ, Wisloff U. Temporal changes in resting heart rate and deaths from ischemic heart disease. Jama 2011;306(23):2579-87.
  2. Winsvold BS, Hagen K, Aamodt AH, Stovner LJ, Holmen J, Zwart JA. Headache, migraine and cardiovascular risk factors: the HUNT study. Eur J Neurol 2011;18(3):504-11.
  3. Sandvei MS, Lindekleiv H, Romundstad PR, et al. Risk factors for aneurysmal subarachnoid hemorrhage - BMI and serum lipids: 11-year follow-up of the HUNT and the Tromso Study in Norway. Acta neurologica Scandinavica 2011.
  4. Nes BM, Janszky I, Vatten LJ, Nilsen TI, Aspenes ST, Wisloff U. Estimating V O2peak from a Nonexercise Prediction Model: The HUNT Study, Norway. Medicine and science in sports and exercise 2011;43(11):2024-30.
  5. Morkedal B, Romundstad PR, Vatten LJ. Informativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II study. European journal of epidemiology 2011;26(6):457-61
  6. Morkedal B, Laugsand LE, Romundstad PR, Vatten LJ. Mortality from ischaemic heart disease: sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study. Eur J Cardiovasc Prev Rehabil 2011;18(5):687-94.
  7. Laugsand LE, Asvold BO, Vatten LJ, et al. Metabolic factors and high-sensitivity C-reactive protein: the HUNT study. Eur J Cardiovasc Prev Rehabil 2011.
  8. Dalen H, Thorstensen A, Romundstad PR, Aase SA, Stoylen A, Vatten LJ. Cardiovascular risk factors and systolic and diastolic cardiac function: a tissue Doppler and speckle tracking echocardiographic study. J Am Soc Echocardiogr 2011;24(3):322-32 e6.
  9. Aspenes ST, Nauman J, Nilsen TI, Vatten L, Wisloff U. Physical Activity as a Long Term Predictor of Peak Oxygen Uptake: The HUNT-Study. Medicine and science in sports and exercise 2011.
  10. Vengen IT, Dale AC, Wiseth R, Midthjell K, Videm V. Lactoferrin is a novel predictor of fatal ischemic heart disease in diabetes mellitus type 2: long-term follow-up of the HUNT 1 study. Atherosclerosis 2010;212(2):614-20.
  11. Tjonna AE, Lund Nilsen TI, Slordahl SA, Vatten L, Wisloff U. The association of metabolic clustering and physical activity with cardiovascular mortality: the HUNT study in Norway. Journal of epidemiology and community health 2010;64(8):690-5.
  12. Romundstad S, Melien O, Holmen J. The G protein beta3 subunit C825T polymorphism is associated with microalbuminuria in hypertensive women and cardiovascular disease in hypertensive men. American journal of hypertension 2010;23(10):1114-20.
  13. Nauman J, Nilsen TI, Wisloff U, Vatten LJ. Combined effect of resting heart rate and physical activity on ischaemic heart disease: mortality follow-up in a population study (the HUNT study, Norway). Journal of epidemiology and community health 2010;64(2):175-81.
  14. Holmen OL, Romundstad S, Melien O. Association between the G protein beta3 subunit C825T polymorphism and the occurrence of cardiovascular disease in hypertensives: The Nord-Trondelag Health Study (HUNT). American journal of hypertension 2010;23(10):1121-7.
  15. Dalen H, Thorstensen A, Aase SA, et al. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr 2010;11(2):176-83.
  16. Dalen H, Thorstensen A, Vatten LJ, Aase SA, Stoylen A. Reference values and distribution of conventional echocardiographic Doppler measures and longitudinal tissue Doppler velocities in a population free from cardiovascular disease. Circulation 2010;3(5):614-22.
  17. Vengen IT, Dale AC, Wiseth R, Midthjell K, Videm V. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study. Atherosclerosis 2009;207(1):239-44.
  18. Dale AC, Midthjell K, Nilsen TI, Wiseth R, Vatten LJ. Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway. European heart journal 2009;30(11):1372-7.
  19. Moholdt T, Wisloff U, Nilsen TI, Slordahl SA. Physical activity and mortality in men and women with coronary heart disease: a prospective population-based cohort study in Norway (the HUNT study). Eur J Cardiovasc Prev Rehabil 2008;15(6):639-45.
  20. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ (Clinical research ed 2008;337:a236.
  21. Dale AC, Nilsen TI, Vatten L, Midthjell K, Wiseth R. Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74,914 individuals in the HUNT 1 Study. European heart journal 2007;28(23):2924-9.
  22. Wisloff U, Nilsen TI, Droyvold WB, Morkved S, Slordahl SA, Vatten LJ. A single weekly bout of exercise may reduce cardiovascular mortality: how little pain for cardiac gain? 'The HUNT study, Norway. Eur J Cardiovasc Prev Rehabil 2006;13(5):798-804.
  23. Romundstad S, Holmen J, Hallan H, Kvenild K, Ellekjaer H. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trondelag Health Study (HUNT), Norway. Circulation 2003;108(22):2783-9.
  24. Romundstad S, Holmen J, Hallan H, Kvenild K, Kruger O, Midthjell K. Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord-Trondelag Health Study (HUNT, 1995-97), Norway. Journal of internal medicine 2002;252(2):164-72.
  25. Ellekjaer H, Holmen J, Vatten L. Blood pressure, smoking and body mass in relation to mortality from stroke and coronary heart disease in the elderly. A 10-year follow-up in Norway. Blood pressure 2001;10(3):156-63.
  26. Claudi T, Midthjell K, Holmen J, Fougner K, Kruger O, Wiseth R. Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: the Nord-Trondelag Diabetes Study, Norway. Journal of internal medicine 2000;248(6):492-500.

Navigation

Want access?

HUNT Biosciences provide a considerable resource for development of personalized medicine

Learn more

Consultancy

HUNT Biosciences provide scientific and regulatory consultancy, and access to several medical Norwegian databases.

Learn more